Note: Ingredients listed on restricted chemical lists
EC/CAS
200-334-9/57-50-1
Name of the chemical
Sucrose, pure C12H22O11
Concentration
<70
EC/CAS
200-578-6/64-17-5
Name of the chemical
Ethanol
Concentration
N/A
EC/CAS
202-222-5/93-14-1
Name of the chemical
Guaifenesin (INN)
Concentration
N/A
EC/CAS
202-307-7/94-13-3
Name of the chemical
Propylparaben; propyl 4-hydroxybenzoate
Concentration
<0.5
EC/CAS
218-690-9/2216-51-5
Name of the chemical
Menthol; dl-menthol; l-menthol; d-menthol (40)
Concentration
<0.1 <5
General Information
Revision date
2018-05-15
Product name
SUDAFED EXPECTORANT SYRUP
Product Synonyms
SUDAFED EXPECTORANT * SUDAFED EXPECTORANT ORAL SOLUTION 30 MG / 5 ML *
Icons in SDS
Company Information
company name
GlaxoSmithKline UK
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
Section 2
EU Classification
Directive 67/548/EEC or 1999/45/EC as amended Exempt from requirements - product regulated as a medicinal product, cosmetic product or medical device. Regulation (EC) No 1272/2008 as amended Exempt from requirements - product regulated as a medicinal product, cosmetic product or medical device.
2.2 Label elements
Label according to Regulation (EC) No. 1272/2008 as amended Exempt from requirements - product regulated as a medicinal product, cosmetic product or medical device.
2.3 Other hazards
Flammable liquid and vapour. See section 11 for additional information on health hazards.
